Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026)
Heron Therapeutics (HRTX) reported Capital Expenditures of $391000.0 for Q1 2026, up 258.72% on a YoY basis from $109000.0 in Q1 2025, and up 87.98% quarter-over-quarter from $208000.0 in Q2 2025.
Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported Capital Expenditures for 17 years, with the latest figure at $391000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 258.72% year-over-year to $391000.0; the trailing twelve-month figure through Mar 2026 stood at $599000.0 (down 58.05% YoY), and the FY2025 full-year result was $317000.0, down 81.42% from the prior year.
- Capital Expenditures for Q1 2026 stood at $391000.0, up from $208000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.0 million in Q1 2022, with the low at $45000.0 in Q3 2022.
- Historically, Capital Expenditures has averaged $395923.1 across 5 years, with a median of $322000.0 in 2022.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 97.06% — and 2023, when it jumped 1662.22%.
- Heron Therapeutics' Capital Expenditures stood at $414000.0 in 2022, then sank by 39.61% to $250000.0 in 2023, then soared by 155.2% to $638000.0 in 2024, then slumped by 67.4% to $208000.0 in 2025, then surged by 87.98% to $391000.0 in 2026.
- The last three Capital Expenditures figures came in at $391000.0 (Q1 2026), $208000.0 (Q2 2025), and $109000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | 391,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 391,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Dec 31, 2022 | 414,000.00 |
| Dec 31, 2022 | 414,000.00 |